Cholera and Shiga toxin bind to the cell surface via glycolipid receptors GM1 and Gb3, respectively. Surprisingly, the majority of Vero cells from a non-synchronized population bind either Cholera or Shiga toxin but not both toxins. The hypothesis that the differential expression of toxin receptors is regulated by the cell cycle was tested. We find that Cholera toxin binds preferentially in G0/G1, with little binding through S-phase to telophase,whereas Shiga toxin binds maximally through G2 to telophase but does not bind during G0/G1 and S-phase. The changes result from the corresponding changes in Gb3 and GM1 synthesis, not from variations of receptor transport to the cell surface. The changes do not reflect competition of Gb3 and GM1 synthesis for lactosylceramide. Cells as diverse as Vero cells, PC12 cells and astrocytes show the same cell-cycle-dependent regulation of glycosphingolipid receptors,suggesting that this novel phenomenon is based on a conserved regulatory mechanism.

How the occupied KDEL receptor ERD2 is sorted into COPI vesicles for Golgi-to-ER transport is largely unknown. Here, interactions between proteins of the COPI transport machinery occurring during a "wave" of transport of a KDEL ligand were studied in living cells. FRET between CFP and YFP fusion proteins was measured by multifocal multiphoton microscopy and bulk-cell spectrofluorimetry. Ligand binding induces oligomerization of ERD2 and recruitment of ARFGAP to the Golgi, where the (ERD2)(n)/ARFGAP complex interacts with membrane-bound ARF1. During KDEL ligand transport, interactions of ERD2 with beta-COP and p23 decrease and the proteins segregate. Both p24a and p23 interact with ARF1, but only p24 interacts with ARFGAP. These findings suggest a model for how cargo-induced oligomerization of ERD2 regulates its sorting into COPI-coated buds.

Although the 11.5 kDa Zn2+-binding protein (ZnBP, parathymosin-alpha) possesses a functional bipartite nuclear localization signal it was found in most tissues in the cytoplasm, The cultivation of freshly isolated rat hepatocytes for 24 hours under standard conditions was associated with an almost complete translocation of ZnBP from the cytoplasm to the nuclei. Here we demonstrate, that this translocation is negatively correlated with cell density. The translocation of ZnBP to the nucleus can be inhibited or abolished by inhibitors of protein synthesis (cycloheximide) or transcription (actinomycin D), Moreover, cycloheximide can induce a relocation of ZnBP to the cytoplasm when applied after the appearance of ZnBP in the nuclei. DMSO, an inhibitor of dedifferentiation of cultured hepatocytes, abolishes also the translocation of ZnBP into the nucleus. Thinly seeded cells keep their ZnBP in the cytoplasm if they are co-cultured with plasma membranes from Morris MH7777 hepatoma cells or antibodies against E-cadherin indicating the involvement of cell adhesion proteins. We have enriched a protein from the cytosol of fresh hepatocytes which inhibits the translocation of ZnBP, but not that of albumin-NLS into the nucleus in a permeabilized cell system. Such an activity could not be found in the cytoplasm of permanent cell lines which harbor ZnBP only in the nucleus. A model for the regulation of the nuclear import of ZnBP is proposed.

A cholera toxin mutant (CTX–K63) unable to raise cAMP levels was used to study in Vero cells the retrograde transport of the toxin A subunit (CTX-A–K63), which possesses a COOH-terminal KDEL retrieval signal. Microinjected GTP-γ-S inhibits the internalization as well as Golgi–ER transport of CTX-A–K63. The appearance of CTX-A–K63 in the Golgi induces a marked dispersion of Erd2p and p53 but not of the Golgi marker giantin. Erd2p is translocated under these conditions most likely to the intermediate compartment as indicated by an increased colocalization of Erd2p with mSEC13, a member of the mammalian coat protein II complex. IgGs as well as Fab fragments directed against Erd2p, β-COP, or p23, a new member of the p24 protein family, inhibit or block retrograde transport of CTX-A–K63 from the Golgi without affecting its internalization or its transport to the Golgi. Anti-Erd2p antibodies do not affect the binding of CTX-A to Erd2p, but inhibit the CTX-K63–induced translocation of Erd2p and p53.

Following retrograde transport to the endoplasmic reticulum (ER) the A‐subunit of cholera toxin (CTX‐A) is partially cleaved into CTX‐A1 and CTX‐A2 by reduction of a disulfide bridge [Majoul et al. (1996) J. Cell Biol. 133, 777–789], although the redox state in the ER favors disulfide formation. We show here that the disulfide bridge of CTX‐A is cleaved in vitro already at GSH/GSSG ratios between 1 and 3. Protein disulfide isomerase (PDI) exerts only a minor accelerating effect. Various mixed disulfide intermediates (CTX‐A1‐S‐S‐CTX‐A1; PDI‐S‐S‐A2; PDI‐S‐S‐A1) appear during CTX‐A reduction. These results indicate that in the ER protein disulfide formation and protein disulfide reduction can take place simultaneously.

We have analyzed in Paramecium cells the occurrence and intracellular distribution of the high capacity/low affinity calcium-binding proteins, calsequestrin (CS) and calreticulin (CR) using antibodies against CS from rat skeletal muscle and against CR from rat liver, respectively. As revealed by Western blots, a CS-like protein isolated by affinity chromatography from Paramecium cells comigrated with CS isolated from rat skeletal muscle. The immunoreactivity of this 53 kDa protein band was blocked when the antibodies had been preadsorbed with purified rat CS. A band of identical molecular size was shown to bind 45Ca in overlays. By immunofluorescence and immunogold labeling this CS-like protein was localized selectively to the extended subplasmalemmal calcium stores, the "alveolar sacs", which cover almost the entire cell surface. Concomitantly the 53 kDa 45Ca-binding band became increasingly intense in overlays as we increasingly enriched alveolar sacs. Antibodies against rat CR react with a 61 kDa band but do not cross-react with CS-like protein in Paramecium. These antibodies selectively stained intracellular reticular structures, identified bona fide as endoplasmic reticulum.

Residence of luminal ER proteins is mediated by a cyclic process which involves binding of escaped proteins to a KDEL receptor in a post-ER compartment and redistribution of the ligand-receptor complex back to the ER. We examined the relocation of the KDEL receptor after treatment with the fungal metabolite brefeldin A and compared this with the retrograde transport of the KDEL receptor observed after ligand or receptor overexpression. Incubation with brefeldin A led to the formation of vesicular structures containing the KDEL receptor and ERGIC-53, a marker for the ER-Golgi intermediate compartment. Immunoelectron microscopy revealed that these structures are composed of tubulo-vesicular clusters. The brefeldin A induced vesicular structures were morphologically and biochemically distinct from the ER-Golgi hybrid compartment as demonstrated by double immunofluorescence microscopy and subcellular fractionation. Overexpression of the receptor itself or a lysozyme-KDEL construct led to a shift of the KDEL receptor together with ERGIC-53, an intermediate compartment marker to the ER but not to structures resembling BFA induced vesicular structures. Moreover, overexpression of the receptor resulted in the partial redistribution of marker proteins of the medial Golgi and the trans-Golgi network to ER-like structures. We conclude that the effects of brefeldin A on the redistribution of the KDEL receptor do not reflect physiological events occurring during increased occupancy of the receptor with ligands.

The A2 chain of cholera toxin (CTX) contains a COOH-terminal Lys-Asp-Glu-Leu (KDEL) sequence. We have, therefore, analyzed by immunofluorescence and by subcellular fractionation in Vero cells whether CTX can used to demonstrate a retrograde transport of KDEL proteins from the Golgi to the ER. Immunofluorescence studies reveal that after a pulse treatment with CTX, the CTX-A and B subunits (CTX-A and CTX-B) reach Golgi-like structures after 15-20 min (maximum after 30 min). Between 30 and 90 min, CTX-A (but not CTX-B) appear in the intermediate compartment and in the ER, whereas the CTX-B are translocated to the lysosomes. Subcellular fractionation studies confirm these results: after CTX uptake for 15 min, CTX-A is associated only with endosomal and Golgi compartments. After 30 min, a small amount of CTX-A appears in the ER in a trypsin-resistant form, and after 60 min, a significant amount appears. CTX-A seems to be transported mainly in its oxidized form (CTX-A1-S-S-CTX-A2) from the Golgi to the ER, where it becomes slowly reduced to form free CTX A1 and CTX-A2, as indicated by experiments in which cells were homogenized 30 and 90 min after the onset of CTX uptake in the presence of N-ethylmaleimide. Nocodazol applied after accumulation of CTX in Golgi inhibits the appearance of CTX-A in the ER and delays the increase of 3',5'cAMP, indicating the participation of microtubules in the retrograde Golgi-ER transport.

The subcellular localization and corresponding quaternary state of fluorescent labelled cholera toxin were determined at different time points after exposure to living cells by a novel form of fluorescence confocal microscopy. The compartmentalization and locus of separation of the pentameric B subunits (CTB) from the A subunit (CTA) of the toxin were evaluated on a pixel‐by‐pixel (voxel‐by‐voxel) basis by measuring the fluorescence resonance energy transfer (FRET) between CTB labelled with the sulfoindocyanine dye Cy3 and an antibody against CTA labelled with Cy5. The FRET efficiency was determined by a new technique based on the release of quenching of the Cy3 donor after photodestruction of the Cy5 acceptor in a region of interest within the cell. The results demonstrate vesicular transport of the holotoxin from the plasma membrane to the Golgi compartment with subsequent separation of the CTA and CTB subunits. The CTA subunit is redirected to the plasma membrane by retrograde transport via the endoplasmic reticulum whereas the CTB subunit persists in the Golgi compartment.

Calreticulin was identified by immunochemical and sequence analyses to be the higher molecular mass (60 kDa) component of the polypeptide doublet previously observed in a rat liver Golgi endomannosidase preparation obtained by chromatography on a Glc alpha 1 --> 3Man-containing matrix. The affinity for this saccharide ligand, which paralleled that of endomannosidase and was also observed with purified rat liver calreticulin, suggested that this chaperone has lectin-like binding properties. Studies carried out with immobilized calreticulin and a series of radiolabeled oligosaccharides derived from N-linked carbohydrate units revealed that interactions with this protein were limited to monoglucosylated polymannose components. Although optimal binding occurred with Glc1Man9GlcNAc, substantial interaction with calreticulin was retained after sequential trimming of the polymannose portion down to the Glc1Man5GlcNAc stage. The alpha 1 --> 6-mannose branch point of the oligosaccharide core, however, appeared to be essential for recognition as Glc1Man4GlcNAc did not interact with the calreticulin. The carbohydrate-peptide linkage region had no discernible influence on binding as monoglucosylated oligosaccharides in N-glycosidic linkage interacted with the chaperone to the same extent as in their unconjugated state. The immobilized calreticulin proved to be a highly effective tool for sorting out monoglucosylated polymannose oligosaccharides or glycopeptides from complex mixtures of processing intermediates. The copurification of calreticulin and endomannosidase from a Golgi fraction in comparable amounts and the strikingly similar saccharide specificities of the chaperone and the processing enzyme have suggested a tentative model for the dissociation through glucose removal of calreticulin-glycoprotein complexes in a post-endoplasmic reticulum locale; in this scheme, deglucosylation would be brought about by the action of endomannosidase rather than glucosidase II.

The 11.5-kDa zinc-binding protein (ZnBP, parathymosin-α), a potent inactivator of 1-phosphofructokinase, is found only in the cytoplasm of most tissues despite the presence of the putative nuclear localization signal PKRQKT. Recent reports on nuclear uptake of ZnBP could not exclude the participation of unspecific diffusion. We show here that wild-type ZnBP overexpressed in COS cells accumulates exclusively in the nucleus but that ZnBP with a mutated or deleted PKRQKT motif appears both in the nucleus and in the cytoplasm. In contrast, fusion proteins between ZnBP and parts of the endoplasmic reticulum protein calreticulin required the intact PKRQKT motif for nuclear import. The motif RKR, located nine amino acids upstream of the PKRQKT motif, is also involved in the active nuclear import of ZnBP. In contrast to rat hepatocytes and kidney cells in situ, which have ZnBP almost exclusively in the cytosol, we find ZnBP in Reuber H35 hepatoma cells and normal rat kidney cells only in the nuclei. Freshly isolated rat hepatocytes translocate their ZnBP to the nucleus in <24 h during standard cell culture conditions.

The 38 amino acid peptide pituitary adenylate cyclase activating polypeptide (PACAP) induced a dose dependent increase of catecholamine secretion in cultures of bovine chromaffin cells. This secretagogue activity of PACAP was strictly dependent on the presence of calcium in the culture medium. If calcium was omitted from the medium no effect of PACAP on catecholamine secretion could be detected during an incubation of 20 min. Preincubation of cells with 1 nM PACAP for 5 min facilitated the subsequent nicotine stimulated catecholamine secretion during a 20 min incubation without addition of the peptide. PACAP induced catecholamine secretion was clearly accompanied by a dose dependent increase of intracellular cAMP concentrations. The percentage of cells responding to PACAP with increased catecholamine secretion was assessed by immunocytochemistry of the transient appearance of dopamine-beta-hydroxylase, associated with the membranes of the chromaffin granules on the cell surface during the secretory process. About 70 % of adrenal medullary cells responded to 100 nM PACAP with enhanced secretory activity. Though PACAP stimulated catecholamine secretion, we did not observe major effects on intracellular free calcium concentrations ([Ca2+](i)) as determined with fura-2 by single cell fluorescence microscopy. In maximally 20 % of the cells a rise in [Ca2+](i) in response to a challenge with 500 nM PACAP was observed. Lower concentrations of PACAP were without an effect on [Ca2+](i). These data indicate that the stimulatory action of PACAP on in vitro catecholamine secretion from bovine chromaffin cells is linked to a rise of intracellular cAMP.

We have isolated a population of post-TGN secretory vesicles from hepatocytes. These vesicles of 100–150 nm diameter carry heparan sulfate proteoglycans. Secretory proteins (albumin, apo-lipoprotein E, fibrinogen) are sorted into different post-TGN secretory vesicles. A member of the ARF family of small GTP-binding proteins is associated with these vesicles. A unique peripheral membrane protein of these vesicles (VAPP14) was shown to exist also on the TGN. Brefeldin A leads to a dissociation of VAPP14 from the TGN. Antibodies against VAPP14 inhibit budding of proteoglycan containing vesicles from the TGN in a cell-free system. Inhibition occurred also in the presence of GTP-γ-S. The same type of vesicles exists in H35 Reuber hepatoma cells.

Protein disulfide‐isomerase (PDI) is the best known representative of a growing family of enzymes with thioredoxin domains. Two such proteins with thioredoxin (Trx) domains, CaBP1 and CaBP2 (ERp72), have previously been isolated from rat liver microsomes. Here we report that they, like PDI are substrates for thioredoxin reductase and will catalyze NADPH‐dependent insulin disulfide reduction. The activity of CaBP1 and CaBP2 in this assay was higher than that of PDI but lower than that of E. coli Trx. Furthermore, as isolated the thioredoxin domains of CaBP1 and CaBP2 were in disulfide form as judged by stoichiometric oxidation of 2 and 3 mol of NADPH in CaBP1 and CaBP2, respectively. The redox potential of the active site disulfide/dithiol was estimated from the equilibrium with a mutant E. coli Trx, P34H Trx, with a known redox potential (−235 mV). This showed that CaBP1 and CaBP2, like PDI, have a much higher redox potential than wild type thioredoxin (−270 mV) in agreement with a role in formation of protein disulfide bonds. In conclusion, in vitro CaBP1 and CaBP2 share catalytic properties in thiol disulfide‐interchange reactions with PDI. Thus, the well known activity of PDI is not unique in the endoplasmic reticulum and CaBP1 and CaBP2 may be regarded as functional equivalents.

It has been shown previously that CaBP2, the rat analog of the murine protein ERp72, and CaBP1, the rat analogue of the hamster protein P5, represent members of the protein disulfide isomerase (PDI) family and are able to catalyze the reduction of insulin in the presence of various reductants (Nguyen Van et al., 1993). We have now examined the abilities of CaBP2 and CaBP1 to catalyze the renaturation of denatured reduced model proteins. Both CaBP2 and CaBP1 catalyzed the reappearance of the biological activity of the denatured reduced Fab fragment of a monoclonal anti-human creatine phosphokinase antibody. The reaction rate was positively correlated with the amount of CaBP2 or CaBP1 and dependent on the GSH/GSSG ratio (maximum at GSH/GSSG = 1). Peptide prolyl-cis,trans-isomerase (PPI), which catalyzed some renaturation on its own, showed synergistic effects with PDI, CaBP2, and CaBP1. No synergistic effects could be observed when the combinations CaBP2 + PDI, CaBP1 + PDI, or CaBP2 + CaBP1 were tested. Variation of [Ca2+] between 0 and 1 mM did not have any effect on the rate or amount of renaturation catalyzed by CaBP2, CaBP1, or PDI, nor were these parameters affected by the simultaneous presence of BiP or grp94. Both CaBP2 and CaBP1 catalyzed also the renaturation of denatured reduced ribonuclease AIII in a way that depended on the amounts of CaBP2 or CaBP1 and on the redox potential of the redox system used (GSH/GSSG or CSH/CSSC). PPI alone had no effect on the rate of RNase AIII renaturation and did not significantly affect renaturation catalyzed by PDI, CaBP2, or CaBP1. PDI showed a moderate but significant synergism with CaBP2, and a strong synergism with CaBP1. The results indicate that both CaBP2 and CaBP1 can catalyze the formation of disulfide bonds and protein disulfide isomerization and may thus be involved in the folding of nascent proteins in the secretory pathway. This does not exclude the possibility of additional functions of these proteins in the pre-Golgi compartments.

Annals of the New York Academy of SciencesVolume 733, Issue 1 p. 344-356 ARF and VAPP14: Two Proteins Involved in the Delivery of Heparan Sulfate Proteoglycan from the trans-Golgi Network to the Plasma Membrane WALTER NICKEL, WALTER NICKEL Abteilung Klinische Biochemie Zentrum Innere Medizin Universität Göttingen Robert Koch Straße 40 D-37070 Göttingen, GermanySearch for more papers by this authorNICOLA KIPPER, NICOLA KIPPER Abteilung Klinische Biochemie Zentrum Innere Medizin Universität Göttingen Robert Koch Straße 40 D-37070 Göttingen, GermanySearch for more papers by this authorANDREAS BARTHEL, ANDREAS BARTHEL Abteilung Klinische Biochemie Zentrum Innere Medizin Universität Göttingen Robert Koch Straße 40 D-37070 Göttingen, GermanySearch for more papers by this authorRICHARD A. KAHN, RICHARD A. KAHN Laboratory of Biological Chemistry National Cancer Institute Building 37 Bethesda, Maryland 20892Search for more papers by this authorDIRK FAßHAUER, DIRK FAßHAUER Abteilung Klinische Biochemie Zentrum Innere Medizin Universität Göttingen Robert Koch Straße 40 D-37070 Göttingen, GermanySearch for more papers by this authorHANS-DIETER SÖLING, Corresponding Author HANS-DIETER SÖLING Abteilung Klinische Biochemie Zentrum Innere Medizin Universität Göttingen Robert Koch Straße 40 D-37070 Göttingen, GermanyTo whom correspondence should be sent.Search for more papers by this author WALTER NICKEL, WALTER NICKEL Abteilung Klinische Biochemie Zentrum Innere Medizin Universität Göttingen Robert Koch Straße 40 D-37070 Göttingen, GermanySearch for more papers by this authorNICOLA KIPPER, NICOLA KIPPER Abteilung Klinische Biochemie Zentrum Innere Medizin Universität Göttingen Robert Koch Straße 40 D-37070 Göttingen, GermanySearch for more papers by this authorANDREAS BARTHEL, ANDREAS BARTHEL Abteilung Klinische Biochemie Zentrum Innere Medizin Universität Göttingen Robert Koch Straße 40 D-37070 Göttingen, GermanySearch for more papers by this authorRICHARD A. KAHN, RICHARD A. KAHN Laboratory of Biological Chemistry National Cancer Institute Building 37 Bethesda, Maryland 20892Search for more papers by this authorDIRK FAßHAUER, DIRK FAßHAUER Abteilung Klinische Biochemie Zentrum Innere Medizin Universität Göttingen Robert Koch Straße 40 D-37070 Göttingen, GermanySearch for more papers by this authorHANS-DIETER SÖLING, Corresponding Author HANS-DIETER SÖLING Abteilung Klinische Biochemie Zentrum Innere Medizin Universität Göttingen Robert Koch Straße 40 D-37070 Göttingen, GermanyTo whom correspondence should be sent.Search for more papers by this author First published: September 1994 https://doi.org/10.1111/j.1749-6632.1994.tb17285.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Salminen, A. & P. J. Novick. 1987. A ras-like protein is required for a post-Golgi event in yeast secretion. Cell 49: 527–538. 2 Schmitt, H. D., M. Pruzicha & D. Gallwitz. 1988. Study of a temperature-sensitive mutant of the ras-related YPT1-gene product in yeast suggests a role in regulation of intracellular calcium. Cell 53: 635–647. 3 Segev, N., J. Mulholland & D. Botstein. 1988. The yeast GTP-binding YPT1 protein and a mammalian counterpart are associated with the secretion machinery. Cell 52: 915–925. 4 Zahraoui, A., N. Touchot, P. Chardin & A. Tavitian. 1989. The human Rab genes encode a family of GTP-binding proteins related to the yeast YPT1 and SEC4 products involved in secretion. J. Biol. Chem. 264: 12394–12401. 5 Balch, W. E., R. A. Kahn & R. Schwaninger. 1992. ADP-ribosylation factor is required for vesicular trafficking between the endoplasmic reticulum and the cis-Golgi compartment. J. Biol. Chem. 267: 13053–13061. 6 Chavrier, P., R. G. Parton, H. P. Hauri, K. Simons & M. Zerial. 1990. Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments. Cell 62: 317–329. 7 Goud, B., A. Zahroui, A. Tavitian & J. Saraste. 1990. Small GTP-binding protein associated with the Golgi cisternae. Nature 7: 553–556. 8 Haubruck, H., R. Prange, C. Vorgias & D. Gallwitz. 1989. The ras-related mouse YPT1 protein can functionally replace the YPT1 gene product in yeast. EMBO J. 8: 1427–1432. 9 Schweizer, A., J. A. M. Fransen, T. Bachi, L. Ginsel & H. P. Hauri. 1988. Identification by a monoclonal antibody, of a 53-kDa protein associated with a tubulo-vesicular compartment at the cis-side of the Golgi apparatus. J. Cell Biol. 107: 1643–1653. 10 Taylor, T. C., R. A. Kahn & P. Melacon. 1992. Two distinct members of the ADP-ribosylation factor family of GTP-binding proteins regulate cell-free intra-Golgi transport. Cell 70: 69–79. 11 Vander Sluijs, P., M. Hull, A. Zahraoui, A. Tavitian, B. Goud & I. Mellmann. 1991. The small GTP-binding protein rab4 is associated with early endosomes. Proc. Natl. Acad. Sci. USA 88: 6313–6317. 12 Bucci, C., R. G. Parton, I. H. Mather, H. Stunnenberg, K. Simons, B. Hoflack & M. Zerial. 1992. The small GTPase rab5 functions as a regulatory factor in the early endocytic pathways. Cell 70: 715–728. 13 Lenhard, J. M., R. A. Kahn & P. D. Stahl. 1992. Evidence for ADP-ribosylation factor (ARF) as a regulator of in vitro endosome-endosome fusion. J. Biol. Chem. 267: 13047–13052. 14 Huber, L. A., S. Pimplikar, R. G. Parton, H. Virta, M. Zerial & K. Simons. 1993. Rab8, a small GTPase involved in vesicular traffic between the TGN and the basolateral plasma membrane. J. Cell Biol. 123: 35–45. 15 Fischer V. Mollard, G., G. A. Mignery, M. Baumert, M. S. Perin, T. J. Hanson, P. M. Burger, R. Jahn & T. C. Südhof. 1990. Rab3 is a small GTP binding protein exclusively localized to synaptic vesicles. Proc. Natl. Acad. Sci. USA 87: 1988–1992. 16 Fischer V. Mollard, G., T. C. Südhof & R. Jahn. 1991. A small GTP binding protein dissociates from synapsis during exocytosis. Nature 349: 79–81. 17 Cameron, P. L., T. C. Südhof, R. Jahn & P. De Camilli. 1991. Colocalization of synaptophysin with transferrin receptors: Implications for synaptic vesicle biogenesis. J. Cell Biol. 115: 151–164. 18 Maycox, P. R., E. Link, A. Reetz, S. A. Morris & R. Jahn. 1992. Clathrin-coated vesicles in nervous tissue are involved primarily in synaptic vesicle recycling. J. Cell Biol. 118: 1379–1388. 19 Südhof, T. C. & R. Jahn. 1991. Proteins of synaptic vesicles involved in exocytosis and membrane recycling. Neuron 6: 665–677. 20 Südhof, T. C., P. De Camilli, H. Niemann & R. Jahn. 1993. Membrane fusion machinery: insights from synaptic proteins. Cell 75: 1–4. 21 Tooze, S. A. & W. B. Huttner. 1990. Cell-free protein sorting to regulated and constitutive secretory pathways. Cell 60: 837–847. 22 Graham, J. M. & D. J. Winterbourne. 1988. Subcellular localization of the sulphation reaction of heparan sulphate synthesis and transport of the proteoglycan to the cell surface in rat liver. Biochem. J. 252: 437–445. 23 Verdon, B. & E. G. Berger. 1983. Galactosyl-transferase. Methods Enzymol. Anal. 3: 374–381. 24 Posner, B. I., M. N. Khan & J. J. M. Bergeron. 1985. Peptide hormone receptors in intracellular structures from rat liver. Methods Enzymol. 109: 223. 25 Arouson, N. N. & O. Trouster. 1974. Isolation of rat liver plasma membrane fragments in isotonic sucrose. Methods Enzymol. 31: 90–103. 26 Arvan, P. & J. D. Castle. 1982. Plasma membrane of the rat parotid gland: preparation and partial characterization of a fraction containing the secretory surface. J. Cell Biol. 95: 8–19. 27 Hall, C. W., I. Liebaers, P. Di Natale & E. Neufeld. 1978. Enzymic diagnosis of the genetic mucopolysaccharide storage disorders. Methods Enzymol. 50: 449–450. 28 Brdiczka, D., D. Pette, G. Brunner & F. Miller. 1968. Kompartimentierte Verteilung von Enzymen in Rattenlebermitochondrien. Eur. J. Biochem. 5: 294–304. 29 Nickel, W., L. A. Huber, R. A. Kahn, N. Kipper, A. Barthel, D. Faßhauer & Hans Dieter Söling. 1994. ADP-ribosylation factor (ARF) and a 14 kDa polypeptide are associated with heparan sulfate carrying post-trans-Golgi network secretory vesicles in rat hepatocyes. J. Cell Biol. 125: 721–732. 30 Rothman, J. E. & L. Orci. 1992. Molecular dissection of the secretory pathway. Nature 355: 409–415. 31 Waters, M. G., T. Serafini & J. E. Rothman. 1991. ‘Coatomer’: a cytosolic protein complex containing subunits of non-clathrin-coated Golgi transport vesicles. Nature 349: 248–251. Volume733, Issue1Molecular and Cell Biological Aspects of Gastroenteropancreatic Neuroendocrine Tumor DiseaseSeptember 1994Pages 344-356 ReferencesRelatedInformation

The carboxyl-terminal Lys-Asp-Glu-Leu (KDEL), or a closely-related sequence, is important for ER localization of both lumenal as well as type II membrane proteins. This sequence functions as a retrieval signal at post-ER compartment(s), but the exact compartment(s) where the retrieval occurs remains unresolved. With an affinity-purified antibody against the carboxyl-terminal sequence of the mammalian KDEL receptor, we have investigated its subcellular localization using immunogold labeling on thawed cryosections of different tissues, such as mouse spermatids and rat pancreas, as well as HeLa, Vero, NRK, and mouse L cells. We show that rab1 is an excellent marker of the intermediate compartment, and we use this marker, as well as budding profiles of the mouse hepatitis virus (MHV) in cells infected with this virus, to identify this compartment. Our results demonstrate that the KDEL receptor is concentrated in the intermediate compartment, as well as in the Golgi stack. Lower but significant labeling was detected in the rough ER. In general, only small amounts of the receptor were detected on the trans side of the Golgi stack, including the trans-Golgi network (TGN) of normal cells and tissues. However, some stress conditions, such as infection with vaccinia virus or vesicular stomatitis virus, as well as 20 degrees C or 43 degrees C treatment, resulted in a significant shift of the distribution towards the trans-TGN side of the Golgi stack. This shift could be quantified in HeLa cells stably expressing a TGN marker. No significant labeling was detected in structures distal to the TGN under all conditions tested. After GTP gamma S treatment of permeabilized cells, the receptor was detected in the beta-COP-containing buds/vesicles that accumulate after this treatment, suggesting that these vesicles may transport the receptor between compartments. We propose that retrieval of KDEL-containing proteins occurs at multiple post-ER compartments up to the TGN along the exocytotic pathway, and that within this pathway, the amounts of the receptor in different compartments varies according to physiological conditions.

A cDNA encoding rat CaBP1 has been isolated and sequenced. The deduced polypeptide chain consists of 440 amino acids including two internal thioredoxin-like domains and a C-terminal KDEL retention/retrieval signal. Regarding the high degree of identity to the hamster protein P5, CaBP1 is considered to be the homologous rat protein. Previous work has suggested that CaBP1 is a resident luminal protein of the intermediate compartment (Schweizer, A., Peter, F., Nguyen Van, P., Söling, H.D. and Hauri, H.P. (1993) Eur. J. Cell Biol. 60, 366-370). Our conclusion that CaBP1 is a resident protein of the endoplasmic reticulum and not of the intermediate compartment is based on three different approaches: subcellular fractionation, indirect immunofluorescence and overexpression of CaBP1. Subcellular fractionation of Vero cells in a velocity controlled step gradient led to copurification of CaBP1-containing vesicles and several marker proteins for the ER including calreticulin and alpha-SSRP. The intermediate compartment, as defined by a monoclonal antibody against the marker protein p53 (ERGIC-53), could be separated from these ER markers. Double immunofluorescence analysed by laser scanning microscopy showed no significant colocalization between CaBP1 and p53, but between CaBP1 and calreticulin. In addition experiments, Vero cells were infected with VSV tsO45. At 15 degrees C the VSV-G protein accumulated in punctuate structures representing the intermediate compartment, while CaBP1 maintained its original reticular localization. Even after high-level overexpression in COS cells, CaBP1 was not detected in the intermediate compartment, but was efficiently retained in the ER as judged by light microscopy.

Constitutive secretory vesicles carrying heparan sulfate proteoglycan (HSPG) were identified in isolated rat hepatocytes by pulse-chase experiments with [35S]sulfate and purified by velocity-controlled sucrose gradient centrifugation followed by equilibrium density centrifugation in Nycodenz. Using this procedure, the vesicles were separated from plasma membranes, Golgi, trans-Golgi network (TGN), ER, endosomes, lysosomes, transcytotic vesicles, and mitochondria. The diameter of these vesicles was approximately 100-200 nm as determined by electron microscopy. A typical coat structure as described for intra-Golgi transport vesicles or clathrin-coated vesicles could not be seen, and the vesicles were not associated with the coat protein beta-COP. Furthermore, the vesicles appear to represent a low density compartment (1.05-1.06 g/ml). Other constitutively secreted proteins (rat serum albumin, apolipoprotein E, and fibrinogen) could not be detected in purified HSPG-carrying vesicles, but banded in the denser fractions of the Nycodenz gradient. Moreover, during pulse-chase labeling with [35S]methionine, labeled albumin did not appear in the post-TGN vesicle fraction carrying HSPGs. These findings indicate sorting of HSPGs and albumin into different types of constitutive secretory vesicles in hepatocytes. Two proteins were found to be tightly associated with the membranes of the HSPG carrying vesicles: a member of the ADP ribosylation factor family of small guanine nucleotide-binding proteins and an unknown 14-kD peripheral membrane protein (VAPP14). Concerning the secretory pathway, we conclude from these results that ADP ribosylation factor proteins are not only involved in vesicular transport from the ER via the Golgi to the TGN, but also in vesicular transport from the TGN to the plasma membrane.